StockData
Neumora Therapeutics, Inc. logo

Neumora Therapeutics, Inc. (NMRA) stock

NMRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 2/30
$0.33−0.03 (-9.47%)

Close on Nov 17, 2026Market cap $62.85MP/E –Yield –

Neumora Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Neumora Therapeutics's price to book ratio was 1.8× on Nov 11, 2026, against 2.7× a year earlier. Over the last 2 years it ranged from 0.4× to 6.0×, with a median of 2.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.8×−0.3
2025Dec 31, 20252.2×−0.9
2024Apr 30, 20243.1×+2.0
2023Dec 29, 20231.1×–

More Neumora Therapeutics figures

See a number that looks wrong?